Adoptive immunotherapy with IL 2 is associated with severe cardiovascular toxicities including peripheral and pulmonary edema, hypotension decreased systemic vascular resistance, increased heart rate, and an increased cardiac index. The purpose of this investigation was to determine whether IL 2 alone or in combination with lymphokine-activated killer cells (LAK) cells depress cardiac function using the isolated, perfused, working rat heart preparation. Male Sprague-Dawley rats (250-350 g) were anesthetized and the hearts were removed and placed on the perfusion apparatus. Hearts were perfused with oxygenated Krebs-Henseleit buffer (KHB), or oxygenated KHB containing IL 2 alone, IL 2-Media (cell culture media supplemented with 1,500 U IL 2/ml), LYMPH (cell culture media from cultured mononuclear cells from healthy volunteers), or LAK (cell culture media from cultured lymphocytes harvested from patients receiving IL 2/LAK in the presence of 1,500 U/ml IL 2). The cells were removed before perfusion (n = 9). Cardiac output and coronary flow were measured at 20-min intervals with preload constant (afterload varied or afterload constant (preload varied). The results indicate a significant depression in cardiac function in hearts treated with LAK. This depression was evident at 20 min and was more pronounced at 60 min. Washout of the KHB plus LAK reversed this depression. Thus, IL 2-stimulated/ cultured human mononuclear cells produce a soluble factor that produces a reversible severe depression of cardiac function. (J. Clin. Invest. 1990. 86:845-850.)
Introduction
Since the T cell growth factor IL 2 was described (1) , there have been numerous reports concerning its use in adoptive immunotherapy of metastases from various tumor types (2) (3) (4) (5) (6) (7) (8) (9) . Lymphocytes cultured with recombinant IL 2 are transformed into lymphokine-activated killer (LAK)' cells which are capable of lysing tumor cells but show little or no lytic activity toward normal cells (10). Unfortunately, patients receiving IL 2 therapy develop a number of toxicities including, fever, chills, anemia, eosinophilia, hyperbilirubinemia, oliguria, weight gain, gastrointestinal symptoms, peripheral and pulmonary edema, and hypotension (2, 3) . Of these toxicities, the cardiovascular side effects are dose limiting for this immunotherapy regimen.
IL 2 induces a hemodynamic state that mimics that seen in patients with septic shock. Patients receiving IL 2 exhibited hypotension, decreased systemic vascular resistance, increased heart rate, and an increased cardiac index (1 1) . Similar findings have been reported by others (7) . These hemodynamic changes associated with this immunotherapy have been attributed, in part, to an increase in capillary permeability, giving rise to a "third-space syndrome" (2, 3, (12) (13) (14) . However, the possibility that IL 2 alone or in combination with LAK cells may have direct, deleterious influences on the heart has not been addressed.
The goal of the present investigation was to investigate the effects of both IL 2 alone and the supernatants from human mononuclear cells incubated with IL 2 on myocardial performance using the isolated, perfused, working rat heart preparation. This model allows the determination of cardiac output and coronary flow under fixed loading conditions. Thus, the model avoids many of the complications in interpretation that may be caused by peripheral actions of IL 2 or LAK cells.
Methods
Animal preparation. Male Sprague-Dawley rats weighing between 250 and 350 g were anesthetized with an intraperitoneal injection of 65 mg/kg sodium pentobarbital. The abdomen was then opened and the animals were anticoagulated with 2 ml of 1:1,000 heparin sodium injected into the inferior vena cava. 1 min was allowed for the heparin to circulate. The chest was then opened and the heart was removed within 20 s after opening the diaphragm. The heart was immediately immersed into a 41C bath of heparinized Krebs-Henseleit buffer (KHB) solution. Contractile activity usually stopped within 15 s. The blotted wet weight was obtained after trimming away excess tissue (lungs, vessels, pericardium, and fat). The aorta was quickly prepared for cannulation.
Isolated heart preparation. The isolated working rat heart model initially described by Neely and co-workers (15) has been modified for use with the addition of an electromagnetic flow probe in the afterload column and with the perfusate temperature maintained at 370C. The standard perfusion medium was a modified KHB, containing (in millimolar): NaCl, 18; KCI, 4.7; MgS04, 1.2; NaHCO3, 25; KH2PO4, 1.2; CaCI2, 2.5; and dextrose, 10.
The heart was placed on the perfusion apparatus by attaching the aorta to the perfusion apparatus cannula with a silk ligature 2-3 mm past the ostia of the coronary arteries. The stopcock was opened, allowing retrograde perfusion to begin. The heart resumed beating within seconds after the retrograde perfusion had begun. The pulmonary artery was opened to decompress the right ventricle. A second cannula was then inserted into the left atrium and secured. A bipolar electrode was attached to the right atrial appendage and paced at 300 bpm for the remainder of the experiment. After a 1 5-min period of retrograde perfusion with perfusion of oxygenated KHB at 90 cmH2O perfusion pressure (left atrium unloaded), the Wet to dry heart weights between groups and before and after perfusion. All groups demonstrated a significant increase in weight with perfusion (P < 0.05) and no significant difference between groups was observed.
cific group means were tested using a two-way ANOVA with repeated measurements over time. Specific group comparisons then performed by modified t test, with the variance obtained from the ANOVA.
Results
Heart weights. The wet heart weights ranged from 0.92 to 1.22 g with no significant differences between groups. After desiccation, the dry left ventricular weights ranged from 0.148 to 0.156 g, again with no significant differences between all groups. All hearts gained weight during the 90-min perfusion but there was no significant difference between groups. The mean heart weights, and weight change during the protocol is shown in Table I .
Cardiac output. Hearts perfused with KHB supplemented with 0, 1, 100, or 10,000 U of IL 2/ml demonstrated no changes in cardiac output during the monitoring period. Fig. 1 shows the cardiac function curves for each concentration. Cardiac output at 90 cm H20 afterload was similar and not significantly different between the control group (IL 2 = 0 U/ml) and the groups receiving different concentrations of IL 2 at each preload tested. Thus, IL 2 alone had no effect on cardiac output. The effects of perfusion with IL 2-Media, LYMPH, and LAK on cardiac output as a function of time are shown in Fig.  2 . Neither IL 2-Media or LYMPH had a significant effect on cardiac output during the 60-min monitoring period. However, LAK media induced a significant reduction (%A = 32; P < 0.001) of cardiac output by 20 min of perfusion. Cardiac output continued to fall during the remainder of the experiment to -46% of the control value after 60 min of exposure. This reduction could be partially reversed by "washing-out" with standard KHB solution if the heart solution exchange took place after only 20 min of exposure to the LAK media, with cardiac output falling from 64.8±4.5 ml/min per g LV at time = 0 falling to 39.5±7.5, and recovering to 56.5±7.4 at 40 min and 47.3±8.5 ml/min per g LV at 60 min. After 60 min of exposure to LAK media, no recovery of function could be obtained by exchanging the media for standard KHB. LAK solutions boiled at 100°C for 5 min caused no reduction in cardiac function (n = 2). Coronaryflow. With the preload fixed at 10 cm H20, coronary flow increased for each increment of afterload from 70 to 100 cm H20. Coronary flow rates ranged from 64±3 to 108±3 for 70 and 100 cm H20 afterload, respectively. This response was seen in all groups, with no significant differences seen between groups.
The effects of perfusion with IL 2-Media (10,000 U/ml), LYMPH, and LAK on coronary flow as a function oftime are shown in Fig. 3 Ventricular function curves were constructed using the data from time = 0 and after 60 min of perfusion with each of the solutions. With the afterload held constant, at 90 cm H20, preload was sequentially changed from 10, 12, 15, 7, and 5 cm H20 while cardiac output was continuously measured. The control ventricular function curves (time = 0) are shown in Fig. 4 A. There were no significant differences between IL 2-Media, LYMPH and LAK groups in cardiac output in response to the increases in preload. The ventricular function curves constructed from the values obtained after 60 min of perfusion are shown in Fig. 4 B. The ventricular function curves remained essentially unchanged in the IL 2-Media and LYMPH group after 60 min of perfusion. However, after 60 min of perfusion with LAK media, there was a significant depression of cardiac function. At 5 cm H20, the cardiac output was decreased by 30%, and by 59% at 15 cm H20 as compared with control (P < 0.001). In the LAK treated group at time = 0, increasing the preload from 5 to 15 cm H20, increased cardiac output by 106%. After 60 min of LAK perfusion, the same increase in preload increased cardiac output by only 50%. Thus, not only were the absolute levels ofcardiac output reduced at each preload after 60 min of perfusion with LAK media, but the ability of the left ventricle to respond to changes in preload was also severely depressed.
Ventricular function curves were also constructed for the conditions of a fixed preload while afterload was changed at time = 0, and after 60 min of perfusion. These are shown in Fig. 5 . Increasing afterload in this range (70-100 cm H20) did not significantly alter cardiac output in any ofthe three groups at time = 0 (Fig. 5 A) . After 60 min of perfusion (Fig. 5 B) , cardiac outputs in the IL 2-Media and LYMPH groups were slightly depressed at each afterload (P > 0.05) compared with time 0. However, the LAK treated group showed a significant depression of cardiac output at each afterload (P < 0.005) compared to time 0, and dramatically reduced (P < 0.0001) function compared with all other media at time = 60 min.
The changes in coronary flow with the preload fixed at 10 cm H20 and afterload varied form 70 to 100 cm H20 at time = 0 60 min are shown in Table II . As expected, coronary flow increased as a function of afterload in all groups at time = 0. After 60 min of perfusion, the absolute level of coronary flow was depressed in both the LYMPH and LAK groups. However, coronary flows increased in all three groups in response to the increase in afterload. The absolute decrease of coronary flow in the 60-min LAK group is most likely attributable to the reduced contractility and reduced myocardial demand for substrate. The vasculature retains its ability to appropriately vasodilate in response to increases of afterload and myocardial work.
Discussion
The findings of the present investigation demonstrate that neither IL 2 nor mononuclear cells in culture alone caused a decrease in cardiac output. However, the supernatant of lymphocytes cultured in media supplemented with IL 2 contains a factor that causes a significant depression of myocardial function. The isolated, perfused working rat heart model allows quantification of myocardial function without the complicating influences of uncontrolled loading conditions, activated blood products, or alterations of substrate availability (oxygen, glucose). The exact mechanism for the observed decrease of function is not known. However, the direct effects ofthe product(s) ofstimulated lymphocytes on the heart have been examined in the absence ofthe reported peripheral clinical toxicities such as peripheral vasodilation and capillary leak (2, 3, 7, 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Note that the model itself precludes the possibility of peripheral events. Although, the end-diastolic pressure was held constant and the end-diastolic volume was not controlled; thus the possibility that a change in chamber compliance with subsequent alterations in the absolute preload occurred cannot be eliminated. However, the ventricular function curves of both time 0 and 60 min approach a plateau for all solutions, suggesting that a change in compliance was not a major contributing factor to the observed change in ventricular function. For compliance alterations to explain the observed fall in stroke volume, increases ofpreload should not have resulted in diminishing increments of stroke volume (plateau effect).
Thus, stimulation of cultured lymphocytes by IL 2 produces a factor that directly reduces myocardial contractile function. 
